| 标题 |
Discovery of synthetic TBK1 activator inducing type I interferon-mediated antiviral and antitumor immunity |
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Type I interferons (IFNs) are central regulators of innate immunity, coordinating antiviral defense and tumor immune surveillance. However, therapeutic strategies that selectively engage IFN signaling while maintaining controlled outputs remain limited. Here, we identify a synthetic small molecule that induces robust type I IFN responses. Mechanistic analyses demonstrate that the compound directly engages TANK-binding kinase 1 (TBK1), leading to IRF3 phosphorylation and selective activation of IFN-stimulated gene programs. In contrast to nucleotide-based innate immune agonists that signal through upstream pattern-recognition receptors, this molecule activates TBK1 through direct chemical engagement. TBK1 activation confers host-directed antiviral activity against coronaviruses, including SARS-CoV-2, through induction of interferon-stimulated genes. |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)